Tag: Viking Therapeutics

As U.S. markets operated on a shortened post-Thanksgiving schedule, research departments remained active, with Viking Therapeutics generating significant analyst enthusiasm. ...

As US markets remain closed for the Thanksgiving holiday, shares of Viking Therapeutics are enjoying a brief respite. The stock ...

After a period of consolidation, Viking Therapeutics stock may be entering another phase of volatility. The biotech firm has scheduled ...

Viking Therapeutics has successfully completed patient enrollment for its pivotal VANQUISH-1 Phase 3 clinical trial ahead of schedule, marking a ...

The competitive landscape for anti-obesity medications has been jolted by a significant development from Viking Therapeutics. The biopharmaceutical company announced ...

Viking Therapeutics has achieved a significant advancement in its obesity treatment program, completing patient enrollment for its pivotal Phase 3 ...

Shares of Viking Therapeutics reached their highest point in ten months during Wednesday's trading session, continuing a significant upward trend. ...

Shares of Viking Therapeutics experienced significant upward momentum this week, fueled by renewed takeover speculation and a positive analyst update. ...

The biotech sector's attention is firmly fixed on Viking Therapeutics as the company prepares for a featured presentation at the ...

Viking Therapeutics has captured significant market attention following the release of impressive clinical trial results for its obesity treatment candidate ...